SOURCE: MIT Holding, Inc.

MIT Holding, Inc.

November 18, 2013 09:00 ET

Orsay Groupe, Inc. Initiates Coverage of MIT Holding $2.80 Price Target by End of Fourth Quarter 2013

SAVANNAH, GA--(Marketwired - Nov 18, 2013) - MIT HOLDING, INC. (OTCQB: MITD) received a coverage with a price target of $2.80. The Orsay Groupe, Inc a Washington D.C. Area based company released a basic research report on the company this morning. Click here for full report.

William Parker, Co-President MITD, states, "We are pleased the Orsay Groupe is spearheading the dissemination of our corporate story and plans for growth. We believe we have successfully re-organized the company for growth through acquisition. The Company's core business and experience should allow MIT Holding to increase revenues and net-earnings on each of the acquisitions being made over the next 48 months."

MIT Holding, Inc through three wholly owned subsidiaries, distributes wholesale pharmaceuticals utilizing compounding pharmacies, administers intravenous infusions and operates an ambulatory center. MIT added new divisions for home medical equipment, an ambulatory center and a compounding pharmacy.

William Nalley, President of Orsay Groupe, said, "In our view, the firm's differentiated business model focusing on medical and technological innovations, enables rapid expansion through acquisitions, new products and therapies. By developing an expansion plan, management intends and expects to capitalize on the growing need to care for the worldwide aging population."

 The target market segments of MIT Holding, Inc.'s closed door pharmacies, nursing homes, hospices, and other medical services are expected to increase dramatically over the foreseeable future. The differentiated business model and growth plans where designed to enhance the value of shareholder positions.

About MIT Holding, Inc. Through its wholly owned subsidiaries, MIT distributes wholesale pharmaceuticals in the United States and overseas, administers intravenous infusions and, in Georgia, operates ambulatory centers where therapies are administered and sells and rents home medical equipment.

About Orsay Groupe, Inc. Communication, marketing and securities law compliance, to enable the most effective two-way communication between your company and your shareholders. Public or Investor Relations needs for your company; and/or

Forward-Looking Statements:
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, but there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.

Contact Information

  • Contact:
    William Nalley